共 50 条
- [22] RETRACTION: LINC00894 Enhances the Progression of Breast Cancer by Sponging miR-429 to Regulate ZEB1 Expression (Retraction of Vol 14, Pg 3395, 2021) ONCOTARGETS AND THERAPY, 2024, 17 : 37 - 38
- [23] RETRACTION: LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p (Retraction of Vol 13, Pg 3589, 2021) CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 9347 - 9347
- [24] RETRACTION: miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 (Retraction of Vol 12, Pg 2719, 2020) CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 12581 - 12581
- [25] RETRACTION: MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK (Retraction of Vol 12, Pg 8137, 2020) CANCER MANAGEMENT AND RESEARCH, 2023, 15 : 487 - 487
- [26] RETRACTION: Circular RNA circGSE1 Promotes Cervical Cancer Progression Through miR-138-5p/Vimentin (Retraction of Vol 13, Pg 13371, 2020) ONCOTARGETS AND THERAPY, 2022, 15 : 759 - 759
- [28] RETRACTION: Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 (Retraction of Vol 13, Pg 6709, 2020) ONCOTARGETS AND THERAPY, 2021, 14 : 123 - 123
- [29] RETRACTION: Novel lncRNA LINC01614 Facilitates Bladder Cancer Proliferation, Migration and Invasion Through the miR-217/RUNX2/Wnt/β-Catenin Axis (Retraction of Vol 13, Pg 8387, 2021) CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2105 - 2105
- [30] RETRACTION: Hsa_circ_0008945 Promoted Breast Cancer Progression by Targeting miR-338-3p (Retraction of Vol 12, Pg 6577, 2019) ONCOTARGETS AND THERAPY, 2023, 16 : 1021 - 1022